Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) is 8.04% higher on its value in year-to-date trading and has touched a low of $168.25 and a high of $368.29 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MDGL stock was last observed hovering at around $323.24 in the last trading session, with the day’s gains setting it 10.15%.
Currently trading at $333.39, the stock is 7.22% and 6.79% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.37 million and changing 3.14% at the moment leaves the stock 28.22% off its SMA200. MDGL registered 44.45% gain for a year compared to 6-month gain of 17.24%. The firm has a 50-day simple moving average (SMA 50) of $312.205 and a 200-day simple moving average (SMA200) of $260.0137.
The stock witnessed a 3.91% loss in the last 1 month and extending the period to 3 months gives it a 53.80%, and is 8.04% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.65% over the week and 3.75% over the month.
Madrigal Pharmaceuticals Inc (MDGL) has around 376 employees, a market worth around $7.27B and $76.81M in sales. Profit margin for the company is -675.24%. Distance from 52-week low is 98.16% and -9.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-57.92%).
The EPS is expected to shrink by -20.51% this year
354.0 institutions hold shares in Madrigal Pharmaceuticals Inc (MDGL), with institutional investors hold 115.75% of the company’s shares. The shares outstanding are 21.81M, and float is at 18.39M with Short Float at 25.74%. Institutions hold 105.84% of the Float.
The top institutional shareholder in the company is JANUS HENDERSON GROUP PLC with over 2.49 million shares valued at $696.33 million. The investor’s holdings represent 12.4278 of the MDGL Shares outstanding. As of 2024-06-30, the second largest holder is AVORO CAPITAL ADVISORS LLC with 2.06 million shares valued at $575.88 million to account for 10.277 of the shares outstanding. The other top investors are BAKER BROS. ADVISORS LP which holds 1.97 million shares representing 9.8722 and valued at over $553.2 million, while RTW INVESTMENTS, LP holds 9.5786 of the shares totaling 1.92 million with a market value of $536.75 million.
Madrigal Pharmaceuticals Inc (MDGL) Insider Activity
The most recent transaction is an insider sale by CRAVES FRED B, the company’s Director. SEC filings show that CRAVES FRED B sold 3,600 shares of the company’s common stock on Dec 03 ’24 at a price of $315.31 per share for a total of $1.14 million. Following the sale, the insider now owns 11000.0 shares.
Madrigal Pharmaceuticals Inc disclosed in a document filed with the SEC on Nov 25 ’24 that CRAVES FRED B (Director) sold a total of 3,400 shares of the company’s common stock. The trade occurred on Nov 25 ’24 and was made at $350.30 per share for $1.19 million. Following the transaction, the insider now directly holds 14600.0 shares of the MDGL stock.
Still, SEC filings show that on Nov 25 ’24, CRAVES FRED B (Director) Proposed Sale 10,000 shares at an average price of $322.73 for $3.23 million. The insider now directly holds shares of Madrigal Pharmaceuticals Inc (MDGL).
